PAYMENT REVIEW OF

ASPEN DIABETES AND ENDOCRINE CLINIC PTE. LTD.

18 JANUARY 2026

ASPEN DIABETES AND ENDOCRINE CLINIC PTE. LTD. (ABN: 201721406E) is a business entity in Singapore registered with The Accounting and Corporate Regulatory Authority (ACRA) and is currently operational. It has a payment reputation rating of 'A' under our scoring framework, and all transactions are recorded in Singapore Dollars (SGD).
Good: 8

Registrar Details

Entity Name
ASPEN DIABETES AND ENDOCRINE CLINIC PTE. LTD.
UEN
201721406E
Entity Status
Live Company
Constitution
Data unavailable
Entity Type
Local Company
Primary Activity (SSIC)
86201
Clinics and other general medical services (Western)
Issuance Agency
ACRA
Registration Incorporation Date
28 July 2017
UEN Issue Date
28 July 2017
Registered Address
6 RAFFLES BOULEVARD MARINA SQUARE #03-308 SINGAPORE 39594
Number of Officers
16
Financial Reporting
Account Due Date
31 July 2026
Annual Return Date
10 July 2025
Audit Firms
Data unavailable
Former Names
  1. FULLERTON SYSTEMS

User Reviews
0

Loading reviews...

Review Anonymously

Help others understand ASPEN DIABETES AND ENDOCRINE CLINIC PTE. LTD.'s payment practices.
A
Payment Rating

Going Concern

PASSED

Legal Name

ASPEN DIABETES AND ENDOCRINE CLINIC PTE. LTD.

Registration Number

201721406E

Country Jurisdiction

SINGAPORE

Registered Date

28 JULY 2017 (8 years 8 months ago)

Base Currency

SINGAPORE DOLLARS

Last Updated

18 JANUARY 2026 10:57 PM

Legal Invoice Recovery
Make a claim on ASPEN DIABETES AND ENDOCRINE CLINIC PTE. LTD.

Frequently Asked Questions

The Payment Rating of ASPEN DIABETES AND ENDOCRINE CLINIC PTE. LTD. is A. It is a proprietary metric aggregating verified public sources (court judgements, news media, financial analysis), community feedback and data partnerships. It indicates the likelihood of on-time payments but is not a financial guarantee.

ASPEN DIABETES AND ENDOCRINE CLINIC PTE. LTD. has passed the "Going Concern" test. This suggest that ASPEN DIABETES AND ENDOCRINE CLINIC PTE. LTD. is operationally active and is likely to be able to meet financial obligations. More specifically, it means ASPEN DIABETES AND ENDOCRINE CLINIC PTE. LTD. does not have significant reported poor payment reviews that is cause for distress and it is also not in the process of being liquidated, winding up, or struck off from the government registry.

Based on the registration date of 28 JULY 2017 12:00 AM, ASPEN DIABETES AND ENDOCRINE CLINIC PTE. LTD. is approximately 9 years old.

The business registration number of ASPEN DIABETES AND ENDOCRINE CLINIC PTE. LTD. is 201721406E. The business registration number is a standard identification number assigned by government registrar to uniquely identify a business entity.

ASPEN DIABETES AND ENDOCRINE CLINIC PTE. LTD. is officially located at 6 RAFFLES BOULEVARD MARINA SQUARE #03-308 SINGAPORE 39594. This is the registered address on file with the registrar.

ASPEN DIABETES AND ENDOCRINE CLINIC PTE. LTD.'s primary industry is Clinics and other general medical services (Western) (SSIC code: 86201).

No. We are an open business directory and review platform. We do not issue credit ratings like Experian, Equifax, or Moody's. Our data, including Payment Ratings, should be used for reference only, not as the sole basis for financial decisions.

Business profile information is provided by official government registries, such as ACRA in Singapore, Australian Business Register, New Zealand Companies Register, and Companies House in the United Kingdom. Payment ratings and reviews are sourced from court notices or judgements, news media, financial analysis, data partnerships and user reported reviews.

Yes. Your identity is protected—reviews are published under the display name 'Anonymous' so businesses cannot identify who wrote them.​ While we verify that reviewers have a legitimate connection to the business (such as being a real supplier or customer), this verification happens privately and is never shared publicly. This approach mirrors how Glassdoor (and Reddit) protects reviewers from retaliation while ensuring reviews come from real people. Avoid including identifying details in your review text (like specific invoice numbers, unique transaction dates, or your company name) that could make you recognizable.

As an open platform, Payre democratizes payment risk information that would otherwise be expensive or difficult to access through traditional credit bureaus. You can share and read actual creditor experiences about late or non-payments to promote a prompt payment culture, influence debtor's management practice and help others make better decisions. We promise reviews to remain freely accessible to anyone.